Welcome PraesensBio

We are excited to welcome new Bio Nebraska member, PraesensBio!

PraesensBio aims to provide superior next-generation sequencing-based infectious disease diagnostics that can be used anywhere in the world, including in low resource environments. We are a privately held company with the mission to create a universal infectious disease diagnostic that is capable of detecting 1000s of pathogens (viral, bacterial, and eukaryotic). Our platform goes beyond syndromic testing to include pathogens that cause enteric (cholera, Norovirus, etc.), respiratory (SARS-CoV-2, influenza, etc.), and febrile (Dengue, malaria, etc.) diseases. Our solution will increase the access to state-of-the-art disease detection and surveillance systems, which will be key in preventing the next epidemic/pandemic.